Differential response to high glucose in skin fibroblasts of monozygotic twins discordant for type 1 diabetes

M. Luiza Caramori, Youngki Kim, Rama Natarajan, Jason H. Moore, Stephen S. Rich, Josyf C. Mychaleckyj, Ryoko Kuriyama, David Kirkpatrick, Michael Mauer

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Context: Most epigenetic studies in diabetes compare normal cells in "high glucose" (HG) to cells in "normal glucose" (NG) and cells returned from HG to NG. Here we challenge this approach. Objective: The objective was to determine whether there were differences in gene expression in skin fibroblasts of monozygotic twins (MZT) discordant for type 1 diabetes (T1D). Design: Skin fibroblasts were grown in NG (5.5 mmol/L) and HG (25 mmol/L) for multiple passages. Setting: This study was conducted at the University of Minnesota. Patients: Patients were nine MZT pairs discordant for T1D. Main Outcome Measure(s): Gene expression was assessed by mRNA-Seq, using the Illumina HiSeq 2000 instrument. Pathway analysis tested directionally consistent group differences within the Kyoto Encyclopedia of Genes and Genomes pathways. Results: A total of 3308 genes were differentially expressed between NG and HG in T1D MZT vs 889 in non-T1D twins. DNA replication, proteasome, cell cycle, base excision repair, homologous recombination, pyrimidine metabolism, and spliceosome pathways had overrepresented genes with increased expression in T1D twins with P values ranging from 7.21 × 10-10 to 1.39 × 10 × -4. In a companion article, we demonstrate that these pathway changes are related to diabetic nephropathy risk. There were no pathways statistically significant differently expressed in nondiabetic twins in HG vs NG. Conclusions: In vivo exposure to diabetes alters cells in a manner that markedly changes their in vitro responsestoHG. These results highlight the importance of using cells directly derived from diabetic patients for studies examining the effects of HG in diabetes.

Original languageEnglish (US)
Pages (from-to)E883-E889
JournalJournal of Clinical Endocrinology and Metabolism
Volume100
Issue number6
DOIs
StatePublished - Jun 1 2015

Fingerprint

Monozygotic Twins
Fibroblasts
Medical problems
Type 1 Diabetes Mellitus
Skin
Glucose
Genes
Gene expression
Encyclopedias
Spliceosomes
Gene Expression
Homologous Recombination
Diabetic Nephropathies
Proteasome Endopeptidase Complex
DNA Replication
Metabolism
Epigenomics
DNA Repair
Cell Cycle
Repair

Cite this

Differential response to high glucose in skin fibroblasts of monozygotic twins discordant for type 1 diabetes. / Caramori, M. Luiza; Kim, Youngki; Natarajan, Rama; Moore, Jason H.; Rich, Stephen S.; Mychaleckyj, Josyf C.; Kuriyama, Ryoko; Kirkpatrick, David; Mauer, Michael.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 100, No. 6, 01.06.2015, p. E883-E889.

Research output: Contribution to journalArticle

Caramori, M. Luiza ; Kim, Youngki ; Natarajan, Rama ; Moore, Jason H. ; Rich, Stephen S. ; Mychaleckyj, Josyf C. ; Kuriyama, Ryoko ; Kirkpatrick, David ; Mauer, Michael. / Differential response to high glucose in skin fibroblasts of monozygotic twins discordant for type 1 diabetes. In: Journal of Clinical Endocrinology and Metabolism. 2015 ; Vol. 100, No. 6. pp. E883-E889.
@article{46bb5493f4d344e088793d80426f12ad,
title = "Differential response to high glucose in skin fibroblasts of monozygotic twins discordant for type 1 diabetes",
abstract = "Context: Most epigenetic studies in diabetes compare normal cells in {"}high glucose{"} (HG) to cells in {"}normal glucose{"} (NG) and cells returned from HG to NG. Here we challenge this approach. Objective: The objective was to determine whether there were differences in gene expression in skin fibroblasts of monozygotic twins (MZT) discordant for type 1 diabetes (T1D). Design: Skin fibroblasts were grown in NG (5.5 mmol/L) and HG (25 mmol/L) for multiple passages. Setting: This study was conducted at the University of Minnesota. Patients: Patients were nine MZT pairs discordant for T1D. Main Outcome Measure(s): Gene expression was assessed by mRNA-Seq, using the Illumina HiSeq 2000 instrument. Pathway analysis tested directionally consistent group differences within the Kyoto Encyclopedia of Genes and Genomes pathways. Results: A total of 3308 genes were differentially expressed between NG and HG in T1D MZT vs 889 in non-T1D twins. DNA replication, proteasome, cell cycle, base excision repair, homologous recombination, pyrimidine metabolism, and spliceosome pathways had overrepresented genes with increased expression in T1D twins with P values ranging from 7.21 × 10-10 to 1.39 × 10 × -4. In a companion article, we demonstrate that these pathway changes are related to diabetic nephropathy risk. There were no pathways statistically significant differently expressed in nondiabetic twins in HG vs NG. Conclusions: In vivo exposure to diabetes alters cells in a manner that markedly changes their in vitro responsestoHG. These results highlight the importance of using cells directly derived from diabetic patients for studies examining the effects of HG in diabetes.",
author = "Caramori, {M. Luiza} and Youngki Kim and Rama Natarajan and Moore, {Jason H.} and Rich, {Stephen S.} and Mychaleckyj, {Josyf C.} and Ryoko Kuriyama and David Kirkpatrick and Michael Mauer",
year = "2015",
month = "6",
day = "1",
doi = "10.1210/jc.2014-4467",
language = "English (US)",
volume = "100",
pages = "E883--E889",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "6",

}

TY - JOUR

T1 - Differential response to high glucose in skin fibroblasts of monozygotic twins discordant for type 1 diabetes

AU - Caramori, M. Luiza

AU - Kim, Youngki

AU - Natarajan, Rama

AU - Moore, Jason H.

AU - Rich, Stephen S.

AU - Mychaleckyj, Josyf C.

AU - Kuriyama, Ryoko

AU - Kirkpatrick, David

AU - Mauer, Michael

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Context: Most epigenetic studies in diabetes compare normal cells in "high glucose" (HG) to cells in "normal glucose" (NG) and cells returned from HG to NG. Here we challenge this approach. Objective: The objective was to determine whether there were differences in gene expression in skin fibroblasts of monozygotic twins (MZT) discordant for type 1 diabetes (T1D). Design: Skin fibroblasts were grown in NG (5.5 mmol/L) and HG (25 mmol/L) for multiple passages. Setting: This study was conducted at the University of Minnesota. Patients: Patients were nine MZT pairs discordant for T1D. Main Outcome Measure(s): Gene expression was assessed by mRNA-Seq, using the Illumina HiSeq 2000 instrument. Pathway analysis tested directionally consistent group differences within the Kyoto Encyclopedia of Genes and Genomes pathways. Results: A total of 3308 genes were differentially expressed between NG and HG in T1D MZT vs 889 in non-T1D twins. DNA replication, proteasome, cell cycle, base excision repair, homologous recombination, pyrimidine metabolism, and spliceosome pathways had overrepresented genes with increased expression in T1D twins with P values ranging from 7.21 × 10-10 to 1.39 × 10 × -4. In a companion article, we demonstrate that these pathway changes are related to diabetic nephropathy risk. There were no pathways statistically significant differently expressed in nondiabetic twins in HG vs NG. Conclusions: In vivo exposure to diabetes alters cells in a manner that markedly changes their in vitro responsestoHG. These results highlight the importance of using cells directly derived from diabetic patients for studies examining the effects of HG in diabetes.

AB - Context: Most epigenetic studies in diabetes compare normal cells in "high glucose" (HG) to cells in "normal glucose" (NG) and cells returned from HG to NG. Here we challenge this approach. Objective: The objective was to determine whether there were differences in gene expression in skin fibroblasts of monozygotic twins (MZT) discordant for type 1 diabetes (T1D). Design: Skin fibroblasts were grown in NG (5.5 mmol/L) and HG (25 mmol/L) for multiple passages. Setting: This study was conducted at the University of Minnesota. Patients: Patients were nine MZT pairs discordant for T1D. Main Outcome Measure(s): Gene expression was assessed by mRNA-Seq, using the Illumina HiSeq 2000 instrument. Pathway analysis tested directionally consistent group differences within the Kyoto Encyclopedia of Genes and Genomes pathways. Results: A total of 3308 genes were differentially expressed between NG and HG in T1D MZT vs 889 in non-T1D twins. DNA replication, proteasome, cell cycle, base excision repair, homologous recombination, pyrimidine metabolism, and spliceosome pathways had overrepresented genes with increased expression in T1D twins with P values ranging from 7.21 × 10-10 to 1.39 × 10 × -4. In a companion article, we demonstrate that these pathway changes are related to diabetic nephropathy risk. There were no pathways statistically significant differently expressed in nondiabetic twins in HG vs NG. Conclusions: In vivo exposure to diabetes alters cells in a manner that markedly changes their in vitro responsestoHG. These results highlight the importance of using cells directly derived from diabetic patients for studies examining the effects of HG in diabetes.

UR - http://www.scopus.com/inward/record.url?scp=84930792430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930792430&partnerID=8YFLogxK

U2 - 10.1210/jc.2014-4467

DO - 10.1210/jc.2014-4467

M3 - Article

VL - 100

SP - E883-E889

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 6

ER -